Using a quantitative high-throughput screening strategy, researchers at the National Institutes of Health (NIH) have identified three new classes of small molecules that may prove useful for treating Gaucher disease, an inherited disorder that disrupts a cell?s ability to break down and dispose of certain cellular waste products.
Tuberculosis (TB) is a major killer, causing up to two million deaths worldwide every year. Treatment takes many months and many patients fail to complete the course of drugs prescribed.
When it comes to giving birth, some traditional approaches could result in happier and healthier moms and newborns, according to two research reviews.
Growth hormone injections appear to boost height in extremely short, healthy children, according to a recent systematic review, but height gain appears to peak at about three inches ? and those inches are expensive.
The commonly used and inexpensive analgesic acetaminophen (Tylenol or paracetamol) is an effective pain reliever after surgical removal of lower wisdom teeth, according to a new systematic review of 21 studies. The most effective dose appears to be 1,000 milligrams taken at six-hour intervals, the review concludes.
The Paul Milstein family has donated $5.5 million to create the Milstein Medical Research Program at Rockefeller University. The initial research efforts will be in the area of skin cancer and will be led by Dr. James G. Krueger, D. Martin Carter Professor and head of the Laboratory for Investigative Dermatology at Rockefeller.
Put aside the white bread and pick up an apple. A diet of foods less likely to spike blood sugar levels helps dieters lose more weight, according to a new systematic review from Australia.
Asking more questions during a visit to the doctor might help patients get care that is more satisfactory, but many patients are not sure where to start.
Back pain is the number one cause of worker-compensation complaints, second only to the common cold in causing lost workdays. Consequently, employers and regulators have pushed training programs to teach specific lifting methods, and some recommend or require the use of assistive devices such as hoists for hospital workers.
Little evidence supports using rosiglitazone (Avandia) to improve the quality or length of life among adults with diabetes, according to a systematic review of data by German researchers.